Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glipizide measurement (procedure) |
Component |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Product containing glipizide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide adverse reaction |
Causative agent (attribute) |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Allergy to glipizide (finding) |
Causative agent (attribute) |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Product containing glipizide and metformin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Allergy to glipizide (finding) |
Causative agent (attribute) |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 10mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glipizide (substance) |
Inferred relationship |
Some |
|
Glipizide 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Product containing glipizide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Product containing glipizide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Product containing only glipizide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide and metformin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Product containing only glipizide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
1 |
Glipizide and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glipizide (substance) |
Inferred relationship |
Some |
2 |